All Stories

  1. Use of Oxidized Regenerated Cellulose in Patients with Lung Cancer: A Biomaterial to Handle with Caution!
  2. Inflammatory breast cancer: is conservative surgery possible?
  3. Commentary: A lymph node mediastinal foreign body reaction mimicking nodal metastasis: a case series
  4. An Innovative Scoring System to Select the Optimal Surgery in Breast Cancer after Neoadjuvant Chemotherapy
  5. Magnetic seed versus skin tattoo localization of non-palpable breast lesions: a single institution cohort study
  6. Tibolone and Breast Tissue: a Review
  7. Precision surgery for breast cancer: current trends and future perspectives
  8. Artificial intelligence (AI) –based machine learning models (ML) for predicting pathological complete response (pCR) in patients with hormone receptor (HoR) –positive/HER2-negative early breast cancer (EBC) undergoing neoadjuvant chemotherapy (NCT): A ...
  9. Local Treatment of Triple-Negative Breast Cancer: Is Mastectomy Superior to Breast-Conserving Surgery?
  10. 138P Activity and efficacy of neoadjuvant chemotherapy (NACT) in luminal-HER2-negative early breast cancer (EBC) according to HER2 score (low vs score 0): A retrospective study
  11. Endocrine Disruptors in Food, Estrobolome and Breast Cancer
  12. Conservative Surgery in cT4 Breast Cancer: Single-Center Experience in the Neoadjuvant Setting
  13. Reducing the environmental impact of surgery on a global scale: systematic review and co-prioritization with healthcare workers in 132 countries
  14. P199 Management and Outcomes of Very Young Women (≤35 Years) with Breast Cancer treated in a single Institution
  15. P231 Prepectoral versus subpectoral single stage breast reconstruction after conservative mastectomy for breast cancer: surgical and oncological outcomes
  16. Selective Axillary Dissection after Neoadjuvant Chemotherapy in Patients with Lymph-Node-Positive Breast Cancer (CLYP Study): The Radio-Guided Occult Lesion Localization Technique for Biopsy-Proven Metastatic Lymph Nodes
  17. Endocrine Disruptors in Food, Estrobolome and Breast Cancer
  18. Upfront surgery or neoadjuvant chemotherapy in young women with breast cancer: results of a retrospective cohort study
  19. Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy
  20. The combined effect and mechanism of antiangiogenic drugs and PD-L1 inhibitor on cell apoptosis in triple negative breast cancer
  21. The Ultrasound Evolution of Lateral Thoracic Perforator Flaps Design and Harvest for Partial and Total Breast Reconstruction
  22. Racial and ethnic disparities in breast cancer survival: critical appraisal of the data emerging from the randomized TAILORx
  23. Paget’s disease of the breast: Our 20 years’ experience
  24. Oncoplastic Breast Surgery versus Conservative Mastectomy in the Management of Large Ductal Carcinoma In Situ (DCIS): Surgical, Oncological, and Patient-Reported Outcomes
  25. Elective surgery system strengthening: development, measurement, and validation of the surgical preparedness index across 1632 hospitals in 119 countries
  26. Prospective Study Investigating the Efficacy and Safety of a Scalp Cooling Device for the Prevention of Alopecia in Women Undergoing (Neo)Adjuvant Chemotherapy for Breast Cancer
  27. BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making
  28. Prepectoral vs. Submuscular Immediate Breast Reconstruction in Patients Undergoing Mastectomy after Neoadjuvant Chemotherapy: Our Early Experience
  29. Lymphatic Tissue Transfer: Ultrasound-Guided Description and Preoperative Planning of Vascularised Lymph Nodes, Lymphatic Units, and Lymphatic Vessels Transfers
  30. Lifestyle counselling and access to integrative treatments in Italian breast centres: Senonetwork national survey
  31. Magnetic Seed versus skin tattoo localization of non-palpable breast lesions: a single institution cohort study
  32. Editorial: Update of Current Evidences in Breast Cancer Surgery
  33. Diagnostic Challenge of Invasive Lobular Carcinoma of the Breast: What Is the News? Breast Magnetic Resonance Imaging and Emerging Role of Contrast-Enhanced Spectral Mammography
  34. Endocrine Disruptors in Food, Estrobolome and Breast Cancer
  35. A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer
  36. 123P Paget’s disease of the breast: Our 20-year experience
  37. 191P Radiotherapy (RT) in oligoprogressive metastatic breast cancer (mBC): A retrospective analysis
  38. Innovations in the Integrated Management of Breast Cancer
  39. Prognostic Factors in Patients with Breast Cancer Liver Metastases Undergoing Liver Resection: Systematic Review and Meta-Analysis
  40. Vitamin D and Histological Features of Breast Cancer: Preliminary Data from an Observational Retrospective Italian Study
  41. Level II Oncoplastic Surgery as an Alternative Option to Mastectomy with Immediate Breast Reconstruction in the Neoadjuvant Setting: A Multidisciplinary Single Center Experience
  42. Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial
  43. Update of Current Evidences in Breast Cancer Surgery
  44. Nipple sparing mastectomy with prepectoral immediate prosthetic reconstruction without acellular dermal matrices: a single center experience
  45. Surgical treatment of breast cancer
  46. Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis
  47. Surgical management of BRCA pathogenic variant carriers with breast cancer: a recent literature review and current state of the art
  48. Techniques for sentinel node biopsy in breast cancer
  49. Breast Cancer Drug Approvals Issued by EMA: A Review of Clinical Trials
  50. Improving Results in Oncoplastic Surgery
  51. SARS‐CoV‐2 infection and venous thromboembolism after surgery: an international prospective cohort study
  52. Let-7a-5p, miR-100-5p, miR-101-3p, and miR-199a-3p Hyperexpression as Potential Predictive Biomarkers in Early Breast Cancer Patients
  53. Effects of pre‐operative isolation on postoperative pulmonary complications after elective surgery: an international prospective cohort study
  54. Breast conserving surgery using oxidized regenerated cellulose as filling biomaterial: recommendations to improve clinical outcomes
  55. Histopathological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) as Predictive Biomarker for Hormone Receptors Status, Proliferative Activity and Clinical Outcome in Her-2 Positive Breast Cancer
  56. Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
  57. How will artificial intelligence impact breast cancer research efficiency?
  58. Decision-making and technical skills to prevent local recurrence after mastectomy for pure ductal carcinoma in situ
  59. Oligometastatic Breast Cancer: How to Manage It?
  60. Letter to the Editor: critical appraisal to optimize clinical and economic impact of oxidized regenerated cellulose in surgical practice
  61. De-escalation of axillary treatment in neoadjuvant setting: recommendations for a successful work
  62. Axillary Nodal Metastases from Carcinoma of Unknown Primary (CUPAx): Role of Contrast-Enhanced Spectral Mammography (CESM) in Detecting Occult Breast Cancer
  63. Breast Cancer-Related Lymphedema: Recent Updates on Diagnosis, Severity and Available Treatments
  64. Hormone Receptor Expression Variations in Normal Breast Tissue: Preliminary Results of a Prospective Observational Study
  65. Immediate implant-based breast reconstruction with acellular dermal matrix after conservative mastectomy: can a more effective alternative be used in the near future?
  66. Neoadjuvant Chemotherapy in Breast Cancer: An Advanced Personalized Multidisciplinary Prehabilitation Model (APMP-M) to Optimize Outcomes
  67. Melanocyte Colonization and Pigmentation of Breast Carcinoma: Description of Two Pathological Cases and Review of Literature
  68. Conventional CT versus Dedicated CT Angiography in DIEP Flap Planning: A Feasibility Study
  69. Myofibroblastoma of the breast: two case reports and literature review
  70. Development of a Digital Research Assistant for the Management of Patients’ Enrollment in Oncology Clinical Trials within a Research Hospital
  71. Different Impact of Definitions of Sarcopenia in Defining Frailty Status in a Population of Older Women with Early Breast Cancer
  72. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
  73. Timing of surgery following SARS-CoV-2 infection
  74. Liver Metastasectomy for Metastatic Breast Cancer Patients: A Single Institution Retrospective Analysis
  75. Sentinel Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer: Preliminary Experience with Clinically Node Negative Patients after Systemic Treatment
  76. Immediate Prosthetic Breast Reconstruction after Nipple-Sparing Mastectomy: Traditional Subpectoral Technique versus Direct-to-Implant Prepectoral Reconstruction without Acellular Dermal Matrix
  77. The Assisi Think Tank Meeting Breast Large Database for Standardized Data Collection in Breast Cancer—ATTM.BLADE
  78. The Key Role of Human Microbiota in Breast Cancer
  79. Image-Guided Localization Techniques for Surgical Excision of Non-Palpable Breast Lesions: An Overview of Current Literature and Our Experience with Preoperative Skin Tattoo
  80. Pregnancy-Associated Breast Cancer: A Multidisciplinary Approach
  81. Decision-Making Skills and Performance of Standardized Tasks Can Optimize Total Operating Time in Breast Cancer Patients Undergoing Mastectomy
  82. GENERATOR Breast DataMart—The Novel Breast Cancer Data Discovery System for Research and Monitoring: Preliminary Results and Future Perspectives
  83. Acellular dermal matrix as filler in breast-conserving surgery: warnings for a careful use
  84. Racial and ethnic disparities in breast cancer survival: critical appraisal of the data emerging from the randomized TAILORx
  85. Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA
  86. Palbociclib Plus Fulvestrant or Everolimus Plus Exemestane for Pretreated Advanced Breast Cancer with Lobular Histotype in ER+/HER2− Patients: A Propensity Score-Matched Analysis of a Multicenter Retrospective Patient Series
  87. PO-0982: Preliminary analysis of radiotherapy role on PFS-2 in oligoprogressive breast cancer
  88. Mastectomy with immediate breast reconstruction during “phase 1” COVID‐19 emergency: An Italian experience
  89. Evidence-based medicine is a valuable tool for a successful decision-making on risk-reducing bilateral mastectomy
  90. Oncotype DX Predictive Nomogram for Recurrence Score Output: The Novel System ADAPTED01 Based on Quantitative Immunochemistry Analysis
  91. Compliance with Specific Recommendations and Tasks Reduces Nipple Necrosis Rates in Prepectoral Implant-Based Reconstruction After Nipple-Sparing Mastectomy
  92. 285P Radiotherapy benefit in oligoprogressive breast cancer: A retrospective analysis
  93. Diagnosis and Treatment of Bone Metastases in Breast Cancer: Radiotherapy, Local Approach and Systemic Therapy in a Guide for Clinicians
  94. Performance of standardized tasks and evidence-based surgery may increase the chance of success in breast conserving treatment
  95. The impact of the COVID‐19 pandemic on breast cancer patients awaiting surgery: Observational survey in an Italian University hospital
  96. Adult Onset Still's Disease and Radiotherapy treatment for breast cancer: Case report about management of this rare association and literature review
  97. Low‐grade myofibroblastic sarcoma of the breast
  98. Transaxillary Nipple-Sparing Mastectomy and Direct-to-Implant Breast Reconstruction Using a Simplified Endoscopic Approach: Indications, Cosmetic Outcomes and Technical Refinements
  99. Actualities on Diagnosis, Targeting and Treating Bone Metastases in Breast Cancer with Radiotherapy and New Drugs
  100. Evidence-based surgery to realize a successful extreme oncoplastic breast conservation
  101. OlympiAD trial: moving to a next level of treatment for patients with BRCA mutation and her2-negative metastatic breast cancer
  102. Evidence-based nipple-sparing mastectomy in patients with higher body mass index: Recommendations for a successful standardized surgery
  103. Oncoplastic Breast-Conserving Surgery
  104. Oral contraceptives and breast cancer risk: An overestimated risk?
  105. Poor efficacy of palbociclib in second‐line treatment of metastatic lobular breast cancer in a case series: Use before or never more?
  106. Menopausal hormone therapy: what should be kept in mind for a personalized choice in a shared decision-making
  107. A Rare Case of Nipple–Areolar Complex Partial Necrosis following Micropigmentation
  108. Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendations to optimize the performance
  109. Results obtained with level II oncoplastic surgery spanning 20 years of breast cancer treatment: Do we really need further demonstration of reliability?
  110. Nipple‐sparing mastectomy combined with endoscopic immediate reconstruction via axillary incision for breast cancer: A preliminary experience of an innovative technique
  111. Hormone replacement therapy
  112. Oncoplastic Breast-Conserving Surgery
  113. Oncoplastic Breast Reconstruction in Conservation Surgery: Steps to Follow for a Successful Work
  114. Contralateral prophylactic mastectomy: What should not be forgotten to improve communication between clinicians and patients!
  115. Internal surgical use of biodegradable carbohydrate polymers. Warning for a conscious and proper use of oxidized regenerated cellulose
  116. Personalized medicine in breast cancer: a step forward
  117. Comment on “Extreme Oncoplastic Surgery for Multifocal/Multicentric and Locally Advanced Breast Cancer”
  118. Breast-conservation Therapy After Neoadjuvant Chemotherapy
  119. Re: Oncoplastic partial breast reconstruction improves patient satisfaction and aesthetic outcome for central breast tumours
  120. Steps to follow in oncoplastic breast surgery to optimise oncological and cosmetic outcome
  121. Transaxillary Nipple-Sparing Mastectomy, Lymphadenectomy and Direct-to-Implant Submuscular Breast Reconstruction Using Endoscopic Technique
  122. Bilateral risk‐reducing mastectomy in BRCA mutation carriers: A difficult decision‐making
  123. What The Surgeons Should Know About The Bilateral Prophylactic Mastectomy in BRCA Mutation Carriers
  124. Shoulder girdle impairment in breast cancer survivors: the role of range of motion as predictive factor for dose distribution and clinical outcome
  125. Extreme oncoplastic breast conserving surgery: Is surgical dexterity all that is need?
  126. EP-1325 Personalized Medicine in breast cancer: a nomogram from prognostic score to deescalate radiotherapy
  127. The role of radiotherapy (RT) in the treatment of Adenoid Cystic Carcinoma of the Breast: case report of RT retreatment and literature review
  128. “Warning” to postoperative complications when using hemostatic agents!
  129. Abstract P1-11-03: Impact of scalp cooling device (SCD) in preventing alopecia in women undergoing chemotherapy for breast cancer
  130. What surgical oncology providers and women with sporadic breast cancer should not forget in the decision-making about contralateral prophylactic mastectomy!
  131. Contralateral prophylactic mastectomy: Warnings for a difficult decision to make with caution!
  132. The modern concept of breast conserving surgery
  133. Update of current evidences in breast cancer multidisciplinary management
  134. New techniques for sentinel node biopsy in breast cancer
  135. Current weaknesses of breast conserving strategies after neoadjuvant chemotherapy in breast cancer treatment
  136. Diagnosis and management of breast lymphoma: a single-institution retrospective analysis
  137. Taking one step backward to take two steps forward: the importance of breast tumor phenotype in MRI-based prediction of response
  138. Current controversies in the treatment of ductal carcinoma in situ of the breast
  139. New challenges in multimodal workout of locally advanced breast cancer
  140. Metastatic giant malignant phyllodes tumor of the breast
  141. Giant Malignant Phyllodes Tumor of the Breast: A Case Report
  142. Hypervascularity Predicts Complete Pathologic Response to Chemotherapy and Late Outcomes in Breast Cancer
  143. Mastectomy in precision oncology era: myth or reality?
  144. The Venous Lymph Node Flap: Concepts, Experimental Evidence, and Potential Clinical Implications
  145. Magnetic resonance imaging appearance of oxidized regenerated cellulose in breast cancer surgery
  146. EP-1181: Prostheses irradiation in breast cancer: clinical and aesthetic outcomes in retrospective series
  147. Penile cancer metastasizing to the breast: a case report
  148. Septum-based cervical lymph-node free flap in rat: a new model
  149. YB-1 in breast cancer. Our laboratory data
  150. Inverted T Skin-Reducing Mastectomy and One-Stage Immediate Implant Reconstruction
  151. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
  152. Mammographic and Ultrasonographic Findings of Oxidized Regenerated Cellulose in Breast Cancer Surgery: A 5-Year Experience
  153. Oxidized regenerated cellulose in breast surgery: experimental model
  154. AMAROS Study: Overall Survival in Breast Cancer Subtypes
  155. Contralateral Breast Symmetrisation in Immediate Prosthetic Breast Reconstruction after Unilateral Nipple-Sparing Mastectomy: The Tailored Reduction/Augmentation Mammaplasty
  156. New trends in breast cancer surgery: a therapeutic approach increasingly efficacy and respectful of the patient
  157. Primary systemic treatment and concomitant low dose radiotherapy for breast cancer: Final results of a prospective phase II study
  158. Effect of breast cancer phenotype on diagnostic performance of MRI in the prediction to response to neoadjuvant treatment
  159. Diffusion magnetic resonance imaging in breast cancer characterisation: correlations between the apparent diffusion coefficient and major prognostic factors
  160. Oncoplastic Breast Surgery with Oxidized Regenerated Cellulose: Appraisals Based on Five-year Experience
  161. The Breast Unit and the Organization of Health Care
  162. Prognostic Role of Human Epidermal Growth Factor Receptor 2 Status in Premenopausal Early Breast Cancer Treated With Adjuvant Tamoxifen
  163. Inverted-T Skin-Reducing Mastectomy with Immediate Implant Reconstruction Using the Submuscular-Subfascial Pocket
  164. EP-0988 COMPARISON OF TWO RADIATION BOOST TECHNIQUES IN PATIENTS UNDERGOING NEOADJUVANT TREATMENT FOR BREAST CANCER
  165. 488 Comparison Between Two Radiation Planning Techniques for the Breast Boost in Patients Who Underwent Neoadjuvant Chemotherapy for Breast Cancer
  166. 466 Benefit of Different Radiation Boost Dose Based on Surgical Margins – Single-institution Experience on 2 173 Patients Treated with Radiotherapy After Breast-conserving Surgery
  167. A Feasibility Study of Neo-Adjuvant Low-Dose Fractionated Radiotherapy with Two Different Concurrent Anthracycline-Docetaxel Schedules in Stage IIA/B-IIIA Breast Cancer
  168. 776 poster THE PRELIMINARY RESULTS OF PHASE II STUDY: NEOADJUVANT CHEMOTHERAPY AND LOW-DOSE RADIOTHERAPY FOR BREAST CANCER
  169. Diffusion-weighted imaging in breast cancer: relationship between apparent diffusion coefficient and tumour aggressiveness
  170. 345 Sentinel lymph node biopsy after neoadjuvant chemotherapy in locally advanced breast cancer patients: feasibility, accuracy and disease upstaging
  171. Early onset lactating adenoma and the role of breast MRI: a case report
  172. Accessory nipple reconstruction following a central quadrantectomy: a case report
  173. Breast MRI in a Case of “Early Onset” Lactating Adenoma
  174. Congenital Tumors of the Retrorectal Space in the Adult: Report of Two Cases and Review of the Literature
  175. Solid breast mass characterisation: use of the sonographic BI-RADS classification
  176. Oncoplastic Techniques in the Conservative Surgical Treatment of Breast Cancer: An Overview
  177. Gastro-intestinal symptoms as clinical manifestation of peritoneal and retroperitoneal spread of an invasive lobular breast cancer: report of a case and review of the literature
  178. Characterization of Solid Breast Masses
  179. ERRATA
  180. Conservative Treatment with Nipple-Areolar Resection for Subareolar Breast Cancer
  181. Synchronous Bilateral Breast Carcinoma in a 50-Year-Old Man with 45,X/46,XY Mosaic Karyotype: Report of a Case
  182. Synchronous Bilateral Paget's Disease of the Nipple Associated with Bilateral Breast Carcinoma
  183. Phyllodes Tumor of the Breast: Magnetic Resonance Imaging Findings and Surgical Treatment
  184. Oncoplastic techniques in the conservative surgical treatment of Breast Cancer
  185. Book Review